Atazanavir sulfate and Agranulocytosis - a phase IV clinical study of FDA data

Summary:

Agranulocytosis is reported as a side effect among people who take Atazanavir sulfate (atazanavir sulfate), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Lamivudine, and have Acquired immunodeficiency syndrome.

The phase IV clinical study analyzes which people have Agranulocytosis when taking Atazanavir sulfate. It is created by eHealthMe based on reports of 4,521 people who have side effects when taking Atazanavir sulfate from the FDA, and is updated regularly.

What is Atazanavir sulfate?

Atazanavir sulfate has active ingredients of atazanavir sulfate. It is often used in hiv infection. eHealthMe is studying from 4,545 Atazanavir sulfate users. Check the latest studies of Atazanavir sulfate.

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,328 drugs and 3,592 conditions by eHealthMe. Check the latest studies of Agranulocytosis.

On Jul, 19, 2026

4,521 people reported to have side effects when taking Atazanavir sulfate.
Among them, 13 people (0.29%) have Agranulocytosis.

Could Atazanavir sulfate cause Agranulocytosis?

Among these 13 people:

How long have people been on Atazanavir sulfate when they have Agranulocytosis? *

What is the gender of people who have Agranulocytosis when taking Atazanavir sulfate? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Agranulocytosis when taking Atazanavir sulfate? *

What are other drugs people take besides Atazanavir sulfate? *

What are other side effects people have besides Agranulocytosis? *

Abdominal Pain: 2 people, 15.38%
Blood Bilirubin Increased: 2 people, 15.38%
Dyspnea (difficult or laboured breathing): 2 people, 15.38%
Weight Increased: 1 person, 7.69%
Abortion Spontaneous (naturally occurring miscarriage): 1 person, 7.69%
Ascites (accumulation of fluid in the abdominal cavity): 1 person, 7.69%
B-Cell Lymphoma Recurrent (blood cancer affecting b cells-recurrent): 1 person, 7.69%
Blood Alkaline Phosphatase Increased: 1 person, 7.69%
Cachexia (loss of weight): 1 person, 7.69%
Dizziness: 1 person, 7.69%

What are the existing conditions these people have? *

Lymphoma Aids Related (cancer of lymph system with aids): 2 people, 15.38%
Hepatitis C: 2 people, 15.38%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 15.38%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 7.69%
Lymphoma (cancer that begins in immune system cells): 1 person, 7.69%
Blood Hiv Rna Increased: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Atazanavir sulfate and have Agranulocytosis?

- Check whether Agranulocytosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atazanavir sulfate:

Atazanavir sulfate (4,545 reports)

Agranulocytosis treatments and more:

Agranulocytosis (213,267 reports)

Browse all side effects of Atazanavir sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Agranulocytosis:

Agranulocytosis (2,328 drugs)

Browse all the conditions that are associated with Agranulocytosis:

Agranulocytosis (3,592 conditions)

Related publications that referenced our studies

Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on atazanavir sulfate (the active ingredients of Atazanavir sulfate) and Atazanavir sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.